OncoPower is a social and care support app for cancer patients and caregivers, providing clinical tools and education on iOS.
The App DNA
What makes this app unique?
Users hire OncoPower to consolidate fragmented cancer journey management into a single interface, reducing the logistical burden of coordinating clinical trials and medication costs.
For Cancer patients, caregivers, and healthcare professionals seeking integrated clinical tools and social support.
What does it look like?
Key features
Private, unlimited Q&A with healthcare professionals via in-app subscription
Pill reminders integrated with Mark Cuban Cost Plus Drug Company pricing
Automated trial matching supported by oncology nurse navigators
How much does it cost?
Freemium model provides broad utility to drive user acquisition while gating professional clinical access behind a paid subscription.
Velocity
Dormant developmentopaqueShow more...
The app has not received a public update in over two and a half years. With no release activity since August 2023, the development momentum is non-existent. There is no evidence of ongoing maintenance, feature development, or live operations support.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for OncoPower
How's the Health & Fitness market?
OncoPower maintains a niche position in the Health & Fitness category, anchored by a 4.6-star rating across 87 reviews on iOS. The lack of recent updates since August 2023 suggests a maintenance-mode posture that risks losing ground to competitors with active development cycles.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for OncoPower
Where is it heading?
The digital health navigation market is shifting toward 24/7 virtual care and automated logistical support. OncoPower's current feature set is stable but lacks the aggressive development cadence required to compete with enterprise-backed rivals, so the PM must shift from maintenance to active feature expansion to remain relevant.
- The absence of feature updates since August 2023 signals a maintenance-mode posture, which risks eroding user trust against active competitors.
- The 4.6-star rating baseline indicates the current feature set meets core user needs, but lacks the momentum to attract new segments.
The SWOT
- Integrated clinical-social support model creates high switching costs
- Mark Cuban Cost Plus Drug Company partnership provides tangible cost-saving mechanism
- Expansion into wearable health monitoring integration
- Untapped B2B distribution through oncology clinic partnerships
Next best moves
Ship real-time video support because competitors like VisionAssist+ capture immediate patient needs → increase user retention
The counter-intuitive read
The lack of 24/7 clinical staff is not…
Read the full takeFeature gaps
Real-time live video assistance (available in VisionAssist+) +1
Since the last report: The platform's competitive positioning has shifted to address the market's move toward 24/7 virtual care, highlighting a critical gap in real-time clinical assistance.
Bottom line
OncoPower provides a valuable centralized hub for cancer care, but the stagnant update cadence leaves it vulnerable to competitors with 24/7 virtual care, so the team must prioritize real-time support to defend its market position.
Unlock 2 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeReport last updated